Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 6676 AL 6690

Editorial: The neurogenetics of brain wiring

Feng T, Chen W, McDonagh A, Liu Z.

Front Genet. 2025 Oct 13;16:1699487. doi: 10.3389/fgene.2025.1699487. eCollection 2025.

Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington's disease decades before clinical motor diagnosis

Scahill RI, Farag M, Murphy MJ, Hobbs NZ, Leocadi M, Langley C, Knights H, Ciosi M, Fayer K, Nakajima M, Thackeray O, Gobom J, Rönnholm J, Weiner S, Hassan YR, Ponraj NKP, Estevez-Fraga C, Parker CS, Malone IB, Hyare H, Long JD, Heslegrave A, Sampaio C, Zhang H, Robbins TW, Zetterberg H, Wild EJ, Rees G, Rowe JB, Sahakian BJ, Monckton DG, Langbehn DR, Tabrizi SJ.

Nat Med. 2025 Mar;31(3):807-818. doi: 10.1038/s41591-024-03424-6. Epub 2025 Jan 17.

The Huntingtin Transport Complex

Prowse ENP, Turkalj BA, Gursu L, Hendricks AG.

Biochemistry. 2025 Feb 18;64(4):760-769. doi: 10.1021/acs.biochem.4c00811. Epub 2025 Feb 5.

Antidopaminergic medications in Huntington's disease

Tan AM, Geva M, Goldberg YP, Schuring H, Sanson BJ, Rosser A, Raymond L, Reilmann R, Hayden MR, Anderson K.

J Huntingtons Dis. 2025 Feb;14(1):16-29. doi: 10.1177/18796397241304312. Epub 2025 Jan 12.

Oxidative Stress in Huntington's Disease

Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Cárcamo-Fonfría A, Caballero-Muñoz MDM, Agúndez JAG.

Biomolecules. 2025 Apr 4;15(4):527. doi: 10.3390/biom15040527.

Huntington's chorea: emerging fields in therapeutics (Review)

Tahir A, Jamal S, Shams UA, Mehmood S.

Neurogenetics. 2025 Sep 6;26(1):66. doi: 10.1007/s10048-025-00848-1.

Protein aggregation in neurodegenerative diseases

Wang J, Dai L, Zhang Z.

Chin Med J (Engl). 2025 Nov 5;138(21):2753-2768. doi: 10.1097/CM9.0000000000003802. Epub 2025 Sep 16.

Novel Compounds for Treating Huntington's Disease

Sabnis RW.

ACS Med Chem Lett. 2025 Jul 31;16(8):1520-1521. doi: 10.1021/acsmedchemlett.5c00442. eCollection 2025 Aug 14.

Pridopidine in early-stage manifest Huntington's disease: a phase 3 trial

Reilmann R, Feigin A, Rosser AE, Kostyk SK, Saft C, Cohen Y, Schuring H, Hand R, Tan AM, Chen K, Feng W, Navon-Perry L, Cruz-Herranz A, Syltevik C, Boot D, Squitieri F, Kayson E, Mehra M, Goldberg YP, Geva M, Hayden MR; PROOF-HD study investigators.

Nat Med. 2025 Nov;31(11):3780-3789. doi: 10.1038/s41591-025-03920-3. Epub 2025 Sep 5.

Update on Genetic Chorea

Pérez-Pérez J, Olmedo-Saura G, Martínez-Horta S, Bernal S, Pagonabarraga J, Kulisevsky J.

Eur J Neurol. 2025 Oct;32(10):e70357. doi: 10.1111/ene.70357.

Neurological and psychiatric phenotype of a multicenter cohort of patients with SETD5-related neurodevelopmental disorder

De Falco A, De Dominicis A, Trivisano M, Specchio N, Digilio MC, Piscopo C, Capra V, Scala M, Iacomino M, Accogli A, Romano F, Salpietro V, Mancardi M, Striano P, Operto FF, Gburek-Augustat J, Perrin L, Capri Y, Lupo V, Elia M, Manti F, Pisani F, Brunetti-Pierri N, Terrone G.

Eur J Paediatr Neurol. 2025 Jan;54:8-17. doi: 10.1016/j.ejpn.2024.11.008. Epub 2024 Nov 23.

Huntington Disease and Chorea

Moore KPL.

Continuum (Minneap Minn). 2025 Aug;31(4):1066-1092. doi: 10.1212/cont.0000000000001597. Epub 2025 Aug 1.

The genetic architecture of fibromyalgia across 2.5 million individuals

Kerrebijn I, Bjornsdottir G, Arbabi K, Urpa L, Haapaniemi H, Thorleifsson G, Stefansdottir L, Frangakis S, Valliere J, Kunorozva L, Abner E, Ji C, Aagaard B, Bliddal H, Brunak S, Bruun MT, Didriksen M, Erikstrup C, Geirsson AJ, Gudbjartsson DF, Hansen TF, Jonsdottir I, Knight S, Knowlton KU, Mikkelsen C, Nadauld LD, Olafsdottir TA, Ostrowski SR, Pedersen OB, Saevarsdottir S, Skuladottir AT, Sørensen E, Stefansson H, Sulem P, Sveinsson OA, Thorlacius GE, Thorsteinsdottir U, Ullum H, Vikingsson A, Werge TM; Chronic Pain Genomics Consortium; FinnGen; DBDS Genomic Consortium; Estonian Biobank Research Team; Genes & Health Research Team; Saxena R, Stefansson K, Brummett CM, Glintborg B, Clauw DJ, Thorgeirsson TE, Williams FM, Sinnott-Armstrong N, Ollila HM, Wainberg M.

medRxiv [Preprint]. 2025 Sep 19:2025.09.18.25335914. doi: 10.1101/2025.09.18.25335914.

Restoring brain barriers: an innovative approach for treating neurological disorders

Lemarchant S, Engelhardt B, Cicchetti F, Bix GJ, Janus A, Godfrin Y, Blasco H, Campbell M, de Rus Jacquet A.

Fluids Barriers CNS. 2025 Jul 10;22(1):72. doi: 10.1186/s12987-025-00688-z.

Current Development of iPSC-Based Modeling in Neurodegenerative Diseases

Guo X, Wang X, Wang J, Ma M, Ren Q.

Int J Mol Sci. 2025 Apr 16;26(8):3774. doi: 10.3390/ijms26083774.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias